“It’s not easy to get the funding to advance truly innovative science — especially to move from an a-ha moment to proof of concept. Granting agencies aren’t willing to take the risk, and biopharmaceutical companies need to see data supporting commercial potential. The Accelerator team believed that ApoGen’s science had significant potential. They were willing to provide funding and technical, operational, and intellectual support. Accelerator was the perfect fit for ApoGen.”

— Reuben Harris, Professor, University of Minnesota (co-founder)